Shree Ganesh Bio-Tech (India) Limited (BOM:539470)
India
· Delayed Price · Currency is INR 0.9000
+0.0500 (5.88%)
At close: May 12, 2025
BOM:539470 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2019 |
| Operating Revenue | 237.35 | 202.78 | 624.55 | 726.44 | 172.14 | 24.73 | Upgrade
|
| Other Revenue | - | - | - | 0 | - | - | Upgrade
|
| Revenue | 237.35 | 202.78 | 624.55 | 726.44 | 172.14 | 24.73 | Upgrade
|
| Revenue Growth (YoY) | -3.01% | -67.53% | -14.03% | 322.01% | 596.07% | -57.86% | Upgrade
|
| Cost of Revenue | 232.44 | 200.31 | 596.29 | 688.37 | 163.3 | 15.75 | Upgrade
|
| Gross Profit | 4.91 | 2.46 | 28.25 | 38.08 | 8.84 | 8.98 | Upgrade
|
| Selling, General & Admin | 1.73 | 1.95 | 2.23 | 2.47 | 0.8 | 0.76 | Upgrade
|
| Other Operating Expenses | 4.73 | 2.52 | 4.52 | 1.11 | 0.96 | 5.84 | Upgrade
|
| Operating Expenses | 6.47 | 4.47 | 6.76 | 3.59 | 1.76 | 6.61 | Upgrade
|
| Operating Income | -1.55 | -2.01 | 21.49 | 34.49 | 7.08 | 2.36 | Upgrade
|
| Interest & Investment Income | 10.56 | 10.56 | 3.31 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 9.76 | -0 | - | -0 | -0 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 18.76 | 8.55 | 24.8 | 34.49 | 7.07 | 2.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 2.34 | 0.5 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -2.79 | - | Upgrade
|
| Pretax Income | 18.76 | 8.55 | 27.14 | 35 | 4.28 | 2.36 | Upgrade
|
| Income Tax Expense | 2.34 | 2.34 | 6.76 | 9.74 | 1.11 | - | Upgrade
|
| Net Income | 16.42 | 6.21 | 20.39 | 25.26 | 3.17 | 2.36 | Upgrade
|
| Net Income to Common | 16.42 | 6.21 | 20.39 | 25.26 | 3.17 | 2.36 | Upgrade
|
| Net Income Growth | - | -69.55% | -19.29% | 697.39% | 34.31% | -86.82% | Upgrade
|
| Shares Outstanding (Basic) | 498 | 399 | 399 | 399 | 399 | 399 | Upgrade
|
| Shares Outstanding (Diluted) | 498 | 399 | 399 | 399 | 399 | 399 | Upgrade
|
| Shares Change (YoY) | 41.69% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.03 | 0.02 | 0.05 | 0.06 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.02 | 0.05 | 0.06 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | - | -68.86% | -21.09% | 697.45% | 34.31% | -86.83% | Upgrade
|
| Free Cash Flow | - | 101.58 | 105.4 | 35.67 | 23.64 | -10.09 | Upgrade
|
| Free Cash Flow Per Share | - | 0.26 | 0.26 | 0.09 | 0.06 | -0.03 | Upgrade
|
| Gross Margin | 2.07% | 1.21% | 4.52% | 5.24% | 5.13% | 36.30% | Upgrade
|
| Operating Margin | -0.65% | -0.99% | 3.44% | 4.75% | 4.11% | 9.56% | Upgrade
|
| Profit Margin | 6.92% | 3.06% | 3.26% | 3.48% | 1.84% | 9.54% | Upgrade
|
| Free Cash Flow Margin | - | 50.09% | 16.88% | 4.91% | 13.73% | -40.79% | Upgrade
|
| EBITDA | -1.55 | -2 | 21.5 | 34.5 | 7.08 | 2.37 | Upgrade
|
| EBITDA Margin | -0.65% | -0.99% | 3.44% | 4.75% | 4.11% | 9.60% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -1.55 | -2.01 | 21.49 | 34.49 | 7.08 | 2.36 | Upgrade
|
| EBIT Margin | -0.65% | -0.99% | 3.44% | 4.75% | 4.11% | 9.56% | Upgrade
|
| Effective Tax Rate | 12.48% | 27.40% | 24.89% | 27.82% | 26.00% | - | Upgrade
|
| Revenue as Reported | 257.67 | 213.34 | 630.19 | 726.95 | 172.14 | 24.73 | Upgrade
|
| Advertising Expenses | - | 0.07 | 0.02 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.